- Home
- UPLD vs CRBP Comparison
UPLD vs CRBP Comparison
Compare UPLD & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPLD
- CRBP
- Stock Information
- Founded
- UPLD 2010
- CRBP 2009
- Country
- UPLD United States
- CRBP United States
- Employees
- UPLD N/A
- CRBP N/A
- Industry
- UPLD Computer Software: Prepackaged Software
- CRBP Biotechnology: Pharmaceutical Preparations
- Sector
- UPLD Technology
- CRBP Health Care
- Exchange
- UPLD Nasdaq
- CRBP Nasdaq
- Market Cap
- UPLD 115.3M
- CRBP 103.6M
- IPO Year
- UPLD 2014
- CRBP N/A
- Fundamental
- Price
- UPLD $4.09
- CRBP $8.18
- Analyst Decision
- UPLD Hold
- CRBP Strong Buy
- Analyst Count
- UPLD 3
- CRBP 8
- Target Price
- UPLD $3.75
- CRBP $61.38
- AVG Volume (30 Days)
- UPLD 167.6K
- CRBP 291.7K
- Earning Date
- UPLD 03-04-2025
- CRBP 03-11-2025
- Dividend Yield
- UPLD N/A
- CRBP N/A
- EPS Growth
- UPLD N/A
- CRBP N/A
- EPS
- UPLD N/A
- CRBP N/A
- Revenue
- UPLD $278,945,000.00
- CRBP N/A
- Revenue This Year
- UPLD N/A
- CRBP N/A
- Revenue Next Year
- UPLD N/A
- CRBP N/A
- P/E Ratio
- UPLD N/A
- CRBP N/A
- Revenue Growth
- UPLD N/A
- CRBP N/A
- 52 Week Low
- UPLD $1.79
- CRBP $7.64
- 52 Week High
- UPLD $5.64
- CRBP $61.90
- Technical
- Relative Strength Index (RSI)
- UPLD 46.14
- CRBP 35.10
- Support Level
- UPLD $4.14
- CRBP $7.64
- Resistance Level
- UPLD $4.79
- CRBP $9.51
- Average True Range (ATR)
- UPLD 0.27
- CRBP 0.84
- MACD
- UPLD 0.02
- CRBP -0.05
- Stochastic Oscillator
- UPLD 33.33
- CRBP 13.71
About UPLD Upland Software Inc.
Upland Software Inc is a provider of cloud-based enterprise work management software. The company provides a family of cloud-based enterprise work management software applications for the information technology, process excellence, finance, professional services and marketing functions within organizations. It services customers ranging from corporations and Government agencies to small- and medium-sized businesses engaged in the field of financial services, retail, technology, manufacturing, education, consumer goods, media, and telecommunications, Government, food and beverage, healthcare and life sciences, chemicals and travel and hospitality. The products of the company are Altify, BA Insight, InGenius, Panviva, Qvidian, RightAnswers and others.
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.